Efficacy of modified face lift incision for the resection of benign parotid gland tumor located anteriorly or superiorly.


Journal

Auris, nasus, larynx
ISSN: 1879-1476
Titre abrégé: Auris Nasus Larynx
Pays: Netherlands
ID NLM: 7708170

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 14 10 2020
revised: 30 12 2020
accepted: 08 01 2021
pubmed: 21 1 2021
medline: 21 12 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

The goals of resection of benign parotid gland tumor are complete resection of lesion and preservation of the facial nerve function. Traditionally, the bayonet-shaped incision (Blair incision: BI) and the modified face lift incision (mFLI) are commonly used for parotidectomy. However, concerns exist about the adequacy of exposure and identification of the facial nerve in anterior or superior parotid lesions. The aim of this study was to compare the surgical outcomes between BI and mFLI and to evaluate the adequacy, possible indications, and limitations of mFLI for the resection of benign parotid gland tumors located anteriorly or superiorly. This retrospective study analyzed the medical records of 175 patients with various types of benign parotid tumor who underwent partial parotidectomy via BI (97 patients) or mFLI (78 patients). Tumors were divided into five categories depending on their location: anterior, superior, inferior, middle, and deep lobe tumors. The outcomes of operation were analyzed according to tumor location between the incision types. Tumor locations were not significantly different between the two groups. Transient facial palsy occurred in 23 out of 152 patients (15.1%); permanent palsy was not observed in either group. The incidence rates of facial palsy were higher among patients with superior and deep lobe tumors; in the mFLI and BI groups, proportions of superior tumors were 22.2% and 27.2%, respectively, and those of deep lobe tumors were 35.7% and 23.5%, respectively. With regard to superior and anterior tumors, the incidence rate of postoperative facial palsy was insignificantly lower in the mFLI group (10.5%) than in the BI group (18.2%). There were no differences in the incidence rates of postoperative facial palsy between mFLI and BI for any tumor location. Use of the mFLI is feasible for the resection of most benign parotid tumors located anteriorly or superiorly.

Identifiants

pubmed: 33468349
pii: S0385-8146(21)00032-8
doi: 10.1016/j.anl.2021.01.014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

978-982

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Auteurs

Fumihiko Matsumoto (F)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan. Electronic address: fmatsu@juntendo.ac.jp.

Shinichi Ohba (S)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Mitsuhisa Fujimaki (M)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Takashi Kojima (T)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Airi Sakyo (A)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Masataka Kojima (M)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Katsuhisa Ikeda (K)

Department of Otorhinolaryngology, Juntendo University Faculty of Medicine Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH